NPM1 antibody | antibody review based on formal publications (original) (raw)

This is a Validated Antibody Database (VAD) review about human NPM1, based on 129 published articles (read how Labome selects the articles), using NPM1 antibody in all methods. It is aimed to help Labome visitors find the most suited NPM1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.

Knockout validation

Abcammouse monoclonal (FC82291) ab10530 western blot knockout validation; human; 1:1000; loading ...; fig 4j Abcam NPM1 antibody (Abcam, Ab10530) was used in western blot knockout validation on human samples at 1:1000 (fig 4j). Nat Commun (2021) ncbi

Invitrogen

mouse monoclonal (FC-61991) 32-5200 immunocytochemistry; hamsters; 5 ug/ml; loading ...; fig 1c Invitrogen NPM1 antibody (Invitrogen, 32-5200) was used in immunocytochemistry on hamsters samples at 5 ug/ml (fig 1c). Int J Med Sci (2022) ncbi
mouse monoclonal (FC-61991) 32-5200 immunocytochemistry; human; 1:1000; loading ...; fig 3c Invitrogen NPM1 antibody (Thermo Fisher, 32-5200) was used in immunocytochemistry on human samples at 1:1000 (fig 3c). Cell Mol Life Sci (2022) ncbi
mouse monoclonal (FC-61991) 32-5200 immunocytochemistry; human; 1:1000; loading ...; fig 2a Invitrogen NPM1 antibody (Invitrogen, 32-5200) was used in immunocytochemistry on human samples at 1:1000 (fig 2a). elife (2021) ncbi
mouse monoclonal (FC-61991) 32-5200 immunocytochemistry; human; loading ...; fig 4d Invitrogen NPM1 antibody (Life Technologies/Invitrogen, 325200) was used in immunocytochemistry on human samples (fig 4d). EMBO Rep (2021) ncbi
mouse monoclonal (FC-61991) 32-5200 immunocytochemistry; mouse; 1:200; fig 6a Invitrogen NPM1 antibody (Thermo Fisher, 32-5200) was used in immunocytochemistry on mouse samples at 1:200 (fig 6a). Nat Commun (2021) ncbi
mouse monoclonal (NA24) MA5-12508 ELISA; human; loading ...; fig s3 Invitrogen NPM1 antibody (Thermo, MA5-12508) was used in ELISA on human samples (fig s3). Sci Rep (2020) ncbi
mouse monoclonal (FC-61991) 32-5200 immunocytochemistry; human; loading ...; fig 1awestern blot; human; loading ...; fig s3d Invitrogen NPM1 antibody (Invitrogen, 32-5200) was used in immunocytochemistry on human samples (fig 1a) and in western blot on human samples (fig s3d). Science (2019) ncbi
mouse monoclonal (FC-61991) 32-5200 immunocytochemistry; human; 1:500; loading ...; fig 1d, 1s2g, 3s3c Invitrogen NPM1 antibody (Thermo Fisher Scientific, 32-5200) was used in immunocytochemistry on human samples at 1:500 (fig 1d, 1s2g, 3s3c). elife (2019) ncbi
mouse monoclonal (FC-61991) 32-5200 western blot; mouse; 1:1000; loading ...; fig s2e Invitrogen NPM1 antibody (Zymed, 32-5200) was used in western blot on mouse samples at 1:1000 (fig s2e). Neuron (2018) ncbi
mouse monoclonal (FC-61991) 32-5200 western blot; human; loading ...; fig s5a In order to investigate the role of ILF2 in RNA splicing and DNA damage response in multiple myeloma, Invitrogen NPM1 antibody (Invitrogen, 325200) was used in western blot on human samples (fig s5a). Cancer Cell (2017) ncbi
mouse monoclonal (FC-61991) 32-5200 immunoprecipitation; human; loading ...immunocytochemistry; human In order to elucidate a mutually regulatory relationship between signal transducer and activator of transcription 5 and nucleophosmin, Invitrogen NPM1 antibody (Invitrogen, 32-5200) was used in immunoprecipitation on human samples and in immunocytochemistry on human samples . Cell Death Dis (2016) ncbi
mouse monoclonal (FC-61991) 32-5200 western blot; human; loading ... In order to investigate the role of XRCC1 protein complexes in normal neurological function and identify PARP1 as a therapeutic target in DNA strand break repair-defective disease, Invitrogen NPM1 antibody (Invitrogen, 325200) was used in western blot on human samples . Nature (2017) ncbi
mouse monoclonal (FC-61991) 32-5200 western blot; human; loading ...; fig 1a In order to examine the functional meaning of oligomerization of NPM1/nucleophosmin, Invitrogen NPM1 antibody (Thermo Fisher, FC-61991) was used in western blot on human samples (fig 1a). Biochem Biophys Res Commun (2016) ncbi
mouse monoclonal (FC-61991) 32-5200 immunohistochemistry; human; loading ...; fig s5a In order to investigate the roles of PARP2 and PARP3 during DNA break repair, Invitrogen NPM1 antibody (Invitrogen, 325200) was used in immunohistochemistry on human samples (fig s5a). Nucleic Acids Res (2017) ncbi
mouse monoclonal (FC-61991) 32-5200 immunocytochemistry; human; loading ...; fig 2bwestern blot; human; loading ...; fig 3 In order to report that PPM1D modulates nucleolar formation by regulating NPM phosphorylation, Invitrogen NPM1 antibody (Invitrogen, FC-61991) was used in immunocytochemistry on human samples (fig 2b) and in western blot on human samples (fig 3). Sci Rep (2016) ncbi
mouse monoclonal (FC-61991) 32-5200 western blot; human; 1:1000; loading ...; fig 3a In order to investigate the DNA/nucleosome and histone chaperone binding activities of H1.X, Invitrogen NPM1 antibody (Thermo Fisher, 32-5200) was used in western blot on human samples at 1:1000 (fig 3a). Mol Cell Biol (2016) ncbi
mouse monoclonal (FC-61991) 32-5200 immunocytochemistry; human; 1:100; fig 4 In order to utilize human oocytes, models of in vitro implantation, and embryos to study expression of placenta-specific 8, Invitrogen NPM1 antibody (Invitrogen, 32-5200) was used in immunocytochemistry on human samples at 1:100 (fig 4). Fertil Steril (2016) ncbi
mouse monoclonal (FC-61991) 32-5200 western blot; human; 1:5000; fig 5 In order to analyze prevention of centrosome amplification and neoplastic progression by 14-3-3gamma, Invitrogen NPM1 antibody (Invitrogen, 325200) was used in western blot on human samples at 1:5000 (fig 5). Sci Rep (2016) ncbi
mouse monoclonal (FC-61991) 32-5200 immunocytochemistry; human; 1:1000; fig 3 In order to study key functions in nucleolar localisation and polyphosphoinositide interaction by a polybasic motif in ErbB3-binding-protein 1 (EBP1), Invitrogen NPM1 antibody (Zymed, 32-5200) was used in immunocytochemistry on human samples at 1:1000 (fig 3). Biochem J (2016) ncbi
mouse monoclonal (FC-61991) 32-5200 western blot; human; fig 3 In order to study NPM-ALK-amplified cell lines resistant to ALK tyrosine kinase inhibitors, Invitrogen NPM1 antibody (Invitrogen, 32-5200) was used in western blot on human samples (fig 3). Oncogene (2016) ncbi
mouse monoclonal (FC-61991) 32-5200 western blot; human In order to identify TRIM28/KAP1 as a novel ARF-binding protein and SUMO E3 ligase for NPM1/B23, Invitrogen NPM1 antibody (Invitrogen, FC-61991) was used in western blot on human samples . Mol Cell Biol (2015) ncbi
mouse monoclonal (FC-61991) 32-5200 immunocytochemistry; human In order to report that TopBP1 and ATR inhibit the synthesis of rRNA and activate the nucleolar stress pathway, Invitrogen NPM1 antibody (Life Technologies, FC-61991) was used in immunocytochemistry on human samples . Nucleic Acids Res (2015) ncbi
mouse monoclonal (FC-61991) 32-5200 western blot; human In order to investigate the effect of CK2-mediated phosphorylation of B23/NPM on specific genes in cancer cells, Invitrogen NPM1 antibody (Zymed, 32-5200) was used in western blot on human samples . Mol Cell Biochem (2015) ncbi
mouse monoclonal (FC-61991) 32-5200 immunocytochemistry; human; 1:1000 Invitrogen NPM1 antibody (Invitrogen, FC-61991) was used in immunocytochemistry on human samples at 1:1000. Blood (2015) ncbi
mouse monoclonal (FC-61991) 32-5200 immunocytochemistry; rat; 1:1000; fig 2 In order to study NADPH oxidase and its dynamic regulation of cytosolic accumulation of small nucleolar RNAS (snoRNAs), Invitrogen NPM1 antibody (Life Technologies, 325200) was used in immunocytochemistry on rat samples at 1:1000 (fig 2). J Biol Chem (2015) ncbi
mouse monoclonal (FC-61991) 32-5200 western blot; human In order to investigate the mechanism for the RNautophagy/DNautophagy effect of LAMP2C, Invitrogen NPM1 antibody (Invitrogen, 32-5200) was used in western blot on human samples . Biochem Biophys Res Commun (2015) ncbi
mouse monoclonal (FC-61991) 32-5200 western blot; human; fig 5 In order to investigate how RNA polymerase I transcription inhibition induces nucleolar disruption and autophagy, Invitrogen NPM1 antibody (Invitrogen, 32-5200) was used in western blot on human samples (fig 5). Sci Rep (2015) ncbi
mouse monoclonal (FC-61991) 32-5200 western blot; mouse; fig s2 In order to test if a viral cyclin-CDK6 complex is a regulator of the Notch receptor, Invitrogen NPM1 antibody (Invitrogen, 32-5200) was used in western blot on mouse samples (fig s2). Cell Cycle (2014) ncbi
mouse monoclonal (FC-61991) 32-5200 immunocytochemistry; mouse; fig s1 In order to assess induced Bax-regulated nuclear rupture and bubble budding followed by release of nuclear proteins due to cellular stress, Invitrogen NPM1 antibody (Invitrogen, 32-5200) was used in immunocytochemistry on mouse samples (fig s1). Nucleus (2014) ncbi
mouse monoclonal (FC-61991) 32-5200 immunocytochemistry; humanwestern blot; human In order to investigate the nucleolar targeting of isopeptidase SENP3, Invitrogen NPM1 antibody (Invitrogen, 32-5200) was used in immunocytochemistry on human samples and in western blot on human samples . Mol Cell Biol (2014) ncbi
mouse monoclonal (FC-61991) 32-5200 immunohistochemistry - paraffin section; humanimmunocytochemistry; human In order to identify and characterize several p53-activating small molecules, Invitrogen NPM1 antibody (Invitrogen, FC-61991) was used in immunohistochemistry - paraffin section on human samples and in immunocytochemistry on human samples . Mol Cancer Ther (2014) ncbi
mouse monoclonal (FC-61991) 32-5200 immunocytochemistry; mouse; fig s9 In order to study why HSC function declines with age, Invitrogen NPM1 antibody (Invitrogen, 32-5200) was used in immunocytochemistry on mouse samples (fig s9). Nature (2014) ncbi
mouse monoclonal (FC-61991) 32-5200 immunocytochemistry; human; 1:200 In order to elucidate TP53-mediated oncogenic transformation of epithelial cells, Invitrogen NPM1 antibody (Invitrogen, FC-61991) was used in immunocytochemistry on human samples at 1:200. Sci Rep (2014) ncbi
mouse monoclonal (FC-61991) 32-5200 western blot; human; 1:500; fig 1 In order to examine NPM1 gene and protein expression in gastric tumors, Invitrogen NPM1 antibody (Invitrogen, FC-61991) was used in western blot on human samples at 1:500 (fig 1). BMC Gastroenterol (2014) ncbi
mouse monoclonal (FC-61991) 32-5200 western blot; human; fig 5 In order to study the mechanisms underlying the regulation of p21 gene expression by TSG101, Invitrogen NPM1 antibody (Zymed Laboratories, clone FC-61991) was used in western blot on human samples (fig 5). PLoS ONE (2013) ncbi
mouse monoclonal (FC-61991) 32-5200 western blot; human; fig 2 In order to study granzyme M-induced cell death, Invitrogen NPM1 antibody (Life Technologies, FC-61991) was used in western blot on human samples (fig 2). Cell Death Differ (2014) ncbi
mouse monoclonal (FC-61991) 32-5200 In order to localize CRM1 and its ribosome export adaptor NMD3 localize and study their roles in rRNA synthesis, Invitrogen NPM1 antibody (Zymed / Invitrogen, 32500) was used . Nucleus (2013) ncbi
mouse monoclonal (FC-61991) 32-5200 western blot; human In order to study the role of Cdk4 and nek2 in binucleation and centrosome amplification in a her2+ breast cancer model, Invitrogen NPM1 antibody (Invitrogen, 32-5200) was used in western blot on human samples . PLoS ONE (2013) ncbi
mouse monoclonal (FC-61991) 32-5200 immunohistochemistry - paraffin section; human; 1:100; fig 2 In order to assess the extracellular matrix in tumor cells cultured in different 3D environments, Invitrogen NPM1 antibody (Zymed, Fc-61991) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 2). Exp Cell Res (2013) ncbi
mouse monoclonal (FC-61991) 32-5200 western blot; human; fig 1 In order to elucidate the role of NPM1-HAUSP in controlling PTEN deubiquitination and trafficking, Invitrogen NPM1 antibody (Invitrogen, #932-5200) was used in western blot on human samples (fig 1). Leukemia (2013) ncbi
mouse monoclonal (FC-61991) 32-5200 western blot; human; 1:1000; fig 4 In order to identify and characterize the role of DDX31 in renal carcinogenesis, Invitrogen NPM1 antibody (Invitrogen, FC-61991) was used in western blot on human samples at 1:1000 (fig 4). Cancer Res (2012) ncbi
mouse monoclonal (FC-61991) 32-5200 western blot; human; fig 12 In order to study the microstructural, physical, and biological properties of a polycaprolactone nanofibrous composite matrix, Invitrogen NPM1 antibody (Invitrogen, 325200) was used in western blot on human samples (fig 12). J Mater Sci Mater Med (2012) ncbi
mouse monoclonal (FC-61991) 32-5200 immunocytochemistry; mouse; fig 5 In order to assess the effects of host aging on mammary tumor growth, Invitrogen NPM1 antibody (Invitrogen, Fc-61991) was used in immunocytochemistry on mouse samples (fig 5). Am J Pathol (2012) ncbi
mouse monoclonal (FC-61991) 32-5200 immunocytochemistry; mouse; 1 ug/ml; fig S7 In order to report that NPM regulates c-Myc nucleolar localization and c-Myc-mediated rDNA transcription, Invitrogen NPM1 antibody (Zymed, Fc-61991) was used in immunocytochemistry on mouse samples at 1 ug/ml (fig S7). Oncogene (2013) ncbi
mouse monoclonal (FC-61991) 32-5200 immunocytochemistry; human; 500 ug/ml In order to discuss methods used to examine the spatial arrangement of nuclear objects, Invitrogen NPM1 antibody (Zymed Laboratories, 32-5200) was used in immunocytochemistry on human samples at 500 ug/ml. PLoS ONE (2012) ncbi
mouse monoclonal (FC-61991) 32-5200 western blot; human; 1 ug/ml; fig 3 In order to report that CIGB-300's antiproliferative activity on tumor cells strongly correlates with its nucleolar localization, Invitrogen NPM1 antibody (Invitrogen, FC-61991) was used in western blot on human samples at 1 ug/ml (fig 3). J Pept Sci (2012) ncbi
mouse monoclonal (FC-61991) 32-5200 immunohistochemistry - paraffin section; human; 1:100; fig 1 In order to determine the nucleophosmin/B23 expression in renal cell carcinomas and renal oncocytomas, Invitrogen NPM1 antibody (ZYMED, FC.61991) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1). APMIS (2012) ncbi
mouse monoclonal (FC-61991) 32-5200 western blot; human; fig s1 In order to test if differences in matrix stiffness affect intracellular signaling through Rho kinase and focal adhesion kinase and subsequently regulate the osteogenic phenotype of MG63 cells, Invitrogen NPM1 antibody (Invitrogen, 325200) was used in western blot on human samples (fig s1). PLoS ONE (2012) ncbi
mouse monoclonal (FC-61991) 32-5200 immunocytochemistry; mouse; fig 1western blot; mouse; fig 6 In order to study the role of ARF in restraining nucleolar ribosome production, Invitrogen NPM1 antibody (Zymed, 32-5200) was used in immunocytochemistry on mouse samples (fig 1) and in western blot on mouse samples (fig 6). Cancer Res (2011) ncbi
mouse monoclonal (FC-61991) 32-5200 immunohistochemistry - paraffin section; human; 1:100; fig 2 In order to investigate prognostic markers of melanoma, Invitrogen NPM1 antibody (ZYMED, FC.61991) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 2). Indian J Pathol Microbiol (2011) ncbi
mouse monoclonal (FC-61991) 32-5200 western blot; human; fig 5 In order to investigate the interactions between SERPINB4 and human GrM, Invitrogen NPM1 antibody (Invitrogen, FC-61991) was used in western blot on human samples (fig 5). PLoS ONE (2011) ncbi
mouse monoclonal (FC-61991) 32-5200 immunocytochemistry; human; fig 1 In order to report that an early reprogramming event remodels ribosomal chromatin and gene expression, Invitrogen NPM1 antibody (Invitrogen, 32-5200) was used in immunocytochemistry on human samples (fig 1). Biochem Biophys Res Commun (2011) ncbi
mouse monoclonal (FC-61991) 32-5200 immunocytochemistry; human; fig 3 In order to identify proteins whose expression is altered in the nucleoli of leukemic cells, Invitrogen NPM1 antibody (ZYMED, 32-5200) was used in immunocytochemistry on human samples (fig 3). Leuk Res (2012) ncbi
mouse monoclonal (FC-61991) 32-5200 immunocytochemistry; human; fig 1 In order to investigate the effect of modulating the rRNA transcription rate on p53 induction in mammalian cells, Invitrogen NPM1 antibody (Zymed, Fc-61991) was used in immunocytochemistry on human samples (fig 1). Oncogene (2011) ncbi
mouse monoclonal (FC-61991) 32-5200 immunocytochemistry; human; fig 3 In order to elucidate the role of SUMO in mammalian ribosome biogenesis, Invitrogen NPM1 antibody (Invitrogen, 32-5200) was used in immunocytochemistry on human samples (fig 3). EMBO J (2011) ncbi
mouse monoclonal (FC-61991) 32-5200 western blot; human; fig 4 In order to investigate how cancer-associated Fbw7 mutations alter binding and localization, Invitrogen NPM1 antibody (Zymed, 32-5200) was used in western blot on human samples (fig 4). Mol Cell Biol (2011) ncbi
mouse monoclonal (FC-61991) 32-5200 immunocytochemistry; human; 1:200; fig 3 In order to study the effect of ribosomal protein gene dose on the activation of p53 in human erythroid progenitor cells, Invitrogen NPM1 antibody (Zymed, 32-5200) was used in immunocytochemistry on human samples at 1:200 (fig 3). Blood (2011) ncbi
mouse monoclonal (FC-61991) 32-5200 western blot; human; fig 1 In order to investigate phosphoinositide-regulated nuclear functions, Invitrogen NPM1 antibody (Zymed, 32-5200) was used in western blot on human samples (fig 1). Mol Cell Proteomics (2011) ncbi
mouse monoclonal (FC-61991) 32-5200 immunoprecipitation; human; fig 5 In order to report that five lysine residues in the APE1 N-terminal unstructured domain are important for the interaction of APE1 with both RNA and NPM1, Invitrogen NPM1 antibody (Invitrogen, FC-61991) was used in immunoprecipitation on human samples (fig 5). Nucleic Acids Res (2010) ncbi
mouse monoclonal (FC-61991) 32-5200 immunocytochemistry; human; fig 2 In order to identify PHF8 as a demethylase of histone H3 lysine 9, Invitrogen NPM1 antibody (Invitrogen, 32-5200) was used in immunocytochemistry on human samples (fig 2). Cell Res (2010) ncbi
mouse monoclonal (FC-61991) 32-5200 western blot; mouse; fig 4 In order to demonstrate that the nucleolar tumor suppressor p19(ARF) suppresses vascular endothelial growth factor A expression, Invitrogen NPM1 antibody (Zymed, FC-61991) was used in western blot on mouse samples (fig 4). Cancer Res (2010) ncbi
mouse monoclonal (FC-61991) 32-5200 immunocytochemistry; human; 1 ug/ml; fig 4 In order to describe the protein profiles of two distinct groups of chronic lymphocytic leukemia, Invitrogen NPM1 antibody (Invitrogen, Fc-61991) was used in immunocytochemistry on human samples at 1 ug/ml (fig 4). Br J Haematol (2010) ncbi
mouse monoclonal (FC-61991) 32-5200 immunohistochemistry; human In order to review the transcription factors that the re-replication inhibitor Geminin binds, Invitrogen NPM1 antibody (Zymed, 32-5200) was used in immunohistochemistry on human samples . BMC Biochem (2009) ncbi
mouse monoclonal (FC-61991) 32-5200 western blot; human In order to study the biological function of human Dna2, Invitrogen NPM1 antibody (Invitrogen, 32-5200) was used in western blot on human samples . Mol Cell Biol (2009) ncbi
mouse monoclonal (FC-61991) 32-5200 western blot; human; 1 ug/ml; fig 2 In order to identify residues critical for p14ARF function, Invitrogen NPM1 antibody (Zymed, FC-61991) was used in western blot on human samples at 1 ug/ml (fig 2). Exp Cell Res (2009) ncbi
mouse monoclonal (FC-61991) 32-5200 immunocytochemistry; humanwestern blot; human In order to identify APE1 partners, Invitrogen NPM1 antibody (Zymed Laboratories, Invitrogen, FC-61991) was used in immunocytochemistry on human samples and in western blot on human samples . Mol Cell Biol (2009) ncbi
mouse monoclonal (FC-61991) 32-5200 immunocytochemistry; mouse; fig 3 In order to investigate the role of RBM19 during mouse embryonic development, Invitrogen NPM1 antibody (Zymed, 32-5200) was used in immunocytochemistry on mouse samples (fig 3). BMC Dev Biol (2008) ncbi
mouse monoclonal (FC-61991) 32-5200 western blot; human; fig 4 In order to examine the role of mitochondrial p32 in ARF-induced apoptosis, Invitrogen NPM1 antibody (Invitrogen, Fc-61991) was used in western blot on human samples (fig 4). Cancer Cell (2008) ncbi
mouse monoclonal (FC-61991) 32-5200 immunoprecipitation; mouse; fig 5immunocytochemistry; mouse; fig 1western blot; mouse; fig 1 In order to study translocation of p14(ARF)/p19(ARF) and B23 into the nucleus, Invitrogen NPM1 antibody (Zymed, FC-61991) was used in immunoprecipitation on mouse samples (fig 5), in immunocytochemistry on mouse samples (fig 1) and in western blot on mouse samples (fig 1). Cancer Res (2008) ncbi
mouse monoclonal (FC-61991) 32-5200 western blot; mouse; fig 5 In order to elucidate how basal NPM and ARF proteins form nucleolar complexes, Invitrogen NPM1 antibody (Zymed, 32-5200) was used in western blot on mouse samples (fig 5). Mol Cell Biol (2008) ncbi
mouse monoclonal (FC-61991) 32-5200 immunocytochemistry; human; fig 4 In order to characterize SAP30L transcripts, Invitrogen NPM1 antibody (Zymed, 32-5200) was used in immunocytochemistry on human samples (fig 4). FEBS Lett (2008) ncbi
mouse monoclonal (FC-61991) 32-5200 immunoprecipitation; human; fig 1western blot; human In order to characterize human JHDM1B, Invitrogen NPM1 antibody (Zymed, 32-5200) was used in immunoprecipitation on human samples (fig 1) and in western blot on human samples . Nature (2007) ncbi
mouse monoclonal (FC-61991) 32-5200 western blot; human In order to examine whether nucleolar localization determines the stability of ARF tumor suppressor gene, Invitrogen NPM1 antibody (Zymed, FC-61991) was used in western blot on human samples . Oncogene (2008) ncbi
mouse monoclonal (FC-61991) 32-5200 western blot; rat; fig 3 In order to elucidate how bystander rat liver cells are stimulated to proliferate, Invitrogen NPM1 antibody (Zymed, 32-5200) was used in western blot on rat samples (fig 3). Proteomics (2007) ncbi
mouse monoclonal (FC-61991) 32-5200 western blot; human In order to investigate the function of nucleophosmin/B23 in cancer cells, Invitrogen NPM1 antibody (Zymed, 32-5200) was used in western blot on human samples . Exp Cell Res (2007) ncbi
mouse monoclonal (FC-61991) 32-5200 immunocytochemistry; human In order to report that SAP30L and SAP30 target Sin3A to the nucleolus, Invitrogen NPM1 antibody (Zymed, 32-5200) was used in immunocytochemistry on human samples . Nucleic Acids Res (2006) ncbi
mouse monoclonal (FC-61991) 32-5200 immunohistochemistry; human; fig 1 In order to assess the role of nucleophosmin exon-12 mutations in adult acute myeloid leukemia, Invitrogen NPM1 antibody (Invitrogen, FC-61991) was used in immunohistochemistry on human samples (fig 1). Blood (2006) ncbi
mouse monoclonal (FC-61991) 32-5200 western blot; human; fig 6 In order to investigate the effects of oxidized low-density lipoprotein treatment on endothelial cells, Invitrogen NPM1 antibody (Zymed, FC-61991) was used in western blot on human samples (fig 6). Free Radic Res (2005) ncbi
mouse monoclonal (FC-61991) 32-5200 immunocytochemistry; human; fig 4Awestern blot; human; fig 4B In order to propose that nucleophosmin is a Ran-Crm1 substrate that controls centrosome duplication, Invitrogen NPM1 antibody (Zymed, FC-61991) was used in immunocytochemistry on human samples (fig 4A) and in western blot on human samples (fig 4B). Nat Cell Biol (2005) ncbi

Abcam

mouse monoclonal (FC82291) ab10530 immunocytochemistry; human; loading ...; fig 2d Abcam NPM1 antibody (Abcam, ab10530) was used in immunocytochemistry on human samples (fig 2d). Sci Adv (2021) ncbi
mouse monoclonal (FC82291) ab10530 western blot; human; 1:1000; loading ...; fig 2d Abcam NPM1 antibody (Abcam, ab10530) was used in western blot on human samples at 1:1000 (fig 2d). Nat Commun (2021) ncbi
mouse monoclonal (FC82291) ab10530 immunocytochemistry; human; loading ...; fig 3awestern blot; human; loading ...; fig 3d Abcam NPM1 antibody (Abcam, ab10530) was used in immunocytochemistry on human samples (fig 3a) and in western blot on human samples (fig 3d). EMBO J (2021) ncbi
mouse monoclonal (3A9F1) ab202579 immunocytochemistry; human; loading ...; fig 5a Abcam NPM1 antibody (Abcam, ab202579) was used in immunocytochemistry on human samples (fig 5a). Molecules (2021) ncbi
mouse monoclonal (FC82291) ab10530 western blot knockout validation; human; 1:1000; loading ...; fig 4j Abcam NPM1 antibody (Abcam, Ab10530) was used in western blot knockout validation on human samples at 1:1000 (fig 4j). Nat Commun (2021) ncbi
mouse monoclonal (3A9F1) ab202579 immunocytochemistry; human; loading ...; fig 4 Abcam NPM1 antibody (Abcam, ab202579) was used in immunocytochemistry on human samples (fig 4). Front Cell Dev Biol (2020) ncbi
mouse monoclonal (FC82291) ab10530 immunohistochemistry - frozen section; human; loading ...; fig 1b, 1c Abcam NPM1 antibody (Abcam, ab10530) was used in immunohistochemistry - frozen section on human samples (fig 1b, 1c). Science (2020) ncbi
mouse monoclonal (FC82291) ab10530 immunocytochemistry; human; 1:50; loading ...; fig 6a Abcam NPM1 antibody (abcam, ab10530) was used in immunocytochemistry on human samples at 1:50 (fig 6a). Int J Mol Sci (2020) ncbi
mouse monoclonal (FC82291) ab10530 western blot; human; loading ...; fig 3e Abcam NPM1 antibody (Abcam, ab10530) was used in western blot on human samples (fig 3e). Cell Death Discov (2020) ncbi
mouse monoclonal (FC82291) ab10530 western blot; mouse; 1:500; loading ...; fig 7d Abcam NPM1 antibody (Abcam, ab10530) was used in western blot on mouse samples at 1:500 (fig 7d). J Biol Chem (2019) ncbi
mouse monoclonal (FC82291) ab10530 Abcam NPM1 antibody (abcam, ab10530) was used . Cell Death Differ (2019) ncbi
mouse monoclonal (FC82291) ab10530 immunocytochemistry; human; 1:100; loading ...; fig 1f In order to show that macroH2A variants aid in maintaining nuclear organization and heterochromatin architecture, Abcam NPM1 antibody (Abcam, ab10530) was used in immunocytochemistry on human samples at 1:100 (fig 1f). J Cell Sci (2017) ncbi
mouse monoclonal (FC82291) ab10530 western blot; human; loading ...; fig 1a Abcam NPM1 antibody (Abcam, ab10530) was used in western blot on human samples (fig 1a). Oncotarget (2016) ncbi
mouse monoclonal (FC82291) ab10530 western blot; human; fig s1 Abcam NPM1 antibody (Abcam, Ab10530) was used in western blot on human samples (fig s1). PLoS ONE (2016) ncbi
domestic rabbit monoclonalab81551 western blot; human; 1:2000; fig 5 In order to analyze prevention of centrosome amplification and neoplastic progression by 14-3-3gamma, Abcam NPM1 antibody (Abcam, ab81551) was used in western blot on human samples at 1:2000 (fig 5). Sci Rep (2016) ncbi
mouse monoclonal (FC82291) ab10530 immunohistochemistry - paraffin section; human; 1:5000; loading ...; fig 6aimmunocytochemistry; human; 1:500; loading ...; fig 1awestern blot; human; loading ...; fig 1c Abcam NPM1 antibody (Abcam, ab10530) was used in immunohistochemistry - paraffin section on human samples at 1:5000 (fig 6a), in immunocytochemistry on human samples at 1:500 (fig 1a) and in western blot on human samples (fig 1c). Oncotarget (2016) ncbi
mouse monoclonal (FC82291) ab10530 western blot; mouse; fig 4immunocytochemistry; human; 1:200; fig s2western blot; human; fig 5 Abcam NPM1 antibody (Abcam, ab10530) was used in western blot on mouse samples (fig 4), in immunocytochemistry on human samples at 1:200 (fig s2) and in western blot on human samples (fig 5). BMC Cell Biol (2015) ncbi
domestic rabbit monoclonal (EP1848Y) ab52644 western blot; human; fig 3 In order to analyze NPM-ALK+ T-cell lymphoma and the transcription factors MZF1 and Ik-1 that downregulate IGF-IR expression, Abcam NPM1 antibody (Abcam, ab52644) was used in western blot on human samples (fig 3). Mol Cancer (2015) ncbi
mouse monoclonal (FC82291) ab10530 western blot; mouse Abcam NPM1 antibody (Abcam, FC82291) was used in western blot on mouse samples . Breast Cancer Res (2015) ncbi
mouse monoclonal (FC82291) ab10530 other; human; fig 2 In order to characterize capabilities and potentials of extracellular vesicle (EV) array, Abcam NPM1 antibody (Abcam, ab10530) was used in other on human samples (fig 2). J Extracell Vesicles (2015) ncbi
domestic rabbit monoclonal (EPR1856) ab109546 western blot; human; fig 4 In order to investigate the effect of CK2-mediated phosphorylation of B23/NPM on specific genes in cancer cells, Abcam NPM1 antibody (Abcam, ab109546) was used in western blot on human samples (fig 4). Mol Cell Biochem (2015) ncbi
mouse monoclonal (FC82291) ab10530 immunoprecipitation; human; loading ...; fig 1aimmunocytochemistry; human; loading ...; fig s1western blot; human; loading ...; fig 6a Abcam NPM1 antibody (Abcam, ab10530) was used in immunoprecipitation on human samples (fig 1a), in immunocytochemistry on human samples (fig s1) and in western blot on human samples (fig 6a). Sci Rep (2015) ncbi
mouse monoclonal (FC82291) ab10530 immunoprecipitation; human; fig 6cwestern blot; human; 1:3000; fig 7g Abcam NPM1 antibody (Abcam, ab10530) was used in immunoprecipitation on human samples (fig 6c) and in western blot on human samples at 1:3000 (fig 7g). Nat Commun (2015) ncbi
mouse monoclonal (FC82291) ab10530 immunocytochemistry; human Abcam NPM1 antibody (Abcam, ab10530) was used in immunocytochemistry on human samples . J Neurochem (2014) ncbi
mouse monoclonal (FC82291) ab10530 western blot; human; fig 2 Abcam NPM1 antibody (Abcam, ab10530) was used in western blot on human samples (fig 2). Oncotarget (2014) ncbi
mouse monoclonal (FC82291) ab10530 immunocytochemistry; mouse Abcam NPM1 antibody (Abcam, ab10530) was used in immunocytochemistry on mouse samples . Stem Cells Dev (2014) ncbi

Santa Cruz Biotechnology

mouse monoclonal (NA24) sc-53175 western blot; human; loading ...; fig 2e Santa Cruz Biotechnology NPM1 antibody (Santa Cruz Biotechnology, sc-53175) was used in western blot on human samples (fig 2e). Nucleic Acids Res (2017) ncbi
mouse monoclonal (0412) sc-47725 western blot; human; fig 3 Santa Cruz Biotechnology NPM1 antibody (Santa Cruz, sc47725) was used in western blot on human samples (fig 3). J Virol (2016) ncbi
mouse monoclonal (FC82291) sc-56622 immunocytochemistry; mouse; 1:200; fig s1 Santa Cruz Biotechnology NPM1 antibody (Santa Cruz, SC56622) was used in immunocytochemistry on mouse samples at 1:200 (fig s1). EMBO J (2016) ncbi
mouse monoclonal (NA24) sc-53175 western blot; human; fig 3 Santa Cruz Biotechnology NPM1 antibody (Santa Cruz, sc-53175) was used in western blot on human samples (fig 3). IUBMB Life (2016) ncbi
mouse monoclonal (NA24) sc-53175 western blot; human In order to investigate the nucleolar targeting of isopeptidase SENP3, Santa Cruz Biotechnology NPM1 antibody (Santa Cruz, NA24) was used in western blot on human samples . Mol Cell Biol (2014) ncbi
mouse monoclonal (FC-8791) sc-32256 immunocytochemistry; human; fig 2 Santa Cruz Biotechnology NPM1 antibody (Santa Cruz, sc-32256) was used in immunocytochemistry on human samples (fig 2). Mol Biol Cell (2014) ncbi
mouse monoclonal (E-3) sc-271737 western blot; human; loading ...; fig 2e Santa Cruz Biotechnology NPM1 antibody (Santa Cruz, sc-271737) was used in western blot on human samples (fig 2e). Sci Rep (2014) ncbi
mouse monoclonal (FC-8791) sc-32256 immunoprecipitation; humanimmunocytochemistry; humanwestern blot; human Santa Cruz Biotechnology NPM1 antibody (Santa Cruz Biotechnology, sc-32256) was used in immunoprecipitation on human samples , in immunocytochemistry on human samples and in western blot on human samples . PLoS ONE (2013) ncbi
mouse monoclonal (FC-8791) sc-32256 chromatin immunoprecipitation; human Santa Cruz Biotechnology NPM1 antibody (Santa Cruz, sc-32256) was used in chromatin immunoprecipitation on human samples . J Virol (2014) ncbi

Novus Biologicals

domestic rabbit polyclonal (HS23) NB110-61646 western blot; mouse; loading ...; fig 1f Novus Biologicals NPM1 antibody (Novus, NB110-61646SS) was used in western blot on mouse samples (fig 1f). Nat Commun (2020) ncbi

Cell Signaling Technology

domestic rabbit monoclonal (D19C1) 3520 western blot; human; 1:1000; loading ...; fig 4d Cell Signaling Technology NPM1 antibody (Cell Signalling Technology, 3520) was used in western blot on human samples at 1:1000 (fig 4d). EMBO Mol Med (2019) ncbi
domestic rabbit polyclonal3542 western blot; human; 1:1000; loading ...; fig 4d Cell Signaling Technology NPM1 antibody (Cell Signalling Technology, 3542) was used in western blot on human samples at 1:1000 (fig 4d). EMBO Mol Med (2019) ncbi
domestic rabbit monoclonal (D19C1) 3520 western blot; human; loading ...; fig 3 In order to report that PPM1D modulates nucleolar formation by regulating NPM phosphorylation, Cell Signaling Technology NPM1 antibody (Cell Signaling, D19C1) was used in western blot on human samples (fig 3). Sci Rep (2016) ncbi
domestic rabbit polyclonal3541 western blot; human; fig 3 In order to study inhibition in hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer cells with acquired resistance to Paclitaxel by effects of CDK4/6, Cell Signaling Technology NPM1 antibody (Cell Signaling Technology, 3541) was used in western blot on human samples (fig 3). J Cancer (2016) ncbi
domestic rabbit polyclonal3542 western blot; human; fig 5 In order to characterize human medulloblastoma-SLCs by microRNAs-proteomic networks, Cell Signaling Technology NPM1 antibody (Cell Signaling Technology, 3542) was used in western blot on human samples (fig 5). Stem Cells Int (2016) ncbi

MilliporeSigma

mouse monoclonal (FC82291) B0556 western blot; human; 1:500; loading ...; fig s3a MilliporeSigma NPM1 antibody (Sigma, B0556) was used in western blot on human samples at 1:500 (fig s3a). J Cell Biol (2021) ncbi
mouse monoclonal (FC82291) B0556 immunocytochemistry; human; 1:1000; loading ...; fig s3c MilliporeSigma NPM1 antibody (Sigma, B0556) was used in immunocytochemistry on human samples at 1:1000 (fig s3c). Sci Adv (2020) ncbi
mouse monoclonal (FC82291) B0556 western blot; mouse; 1:500; loading ...; fig 4c MilliporeSigma NPM1 antibody (Sigma-Aldrich, B0556) was used in western blot on mouse samples at 1:500 (fig 4c). PLoS Biol (2019) ncbi
mouse monoclonal (FC82291) B0556 immunocytochemistry; mouse; loading ...; fig 2s1b MilliporeSigma NPM1 antibody (Sigma, B0556) was used in immunocytochemistry on mouse samples (fig 2s1b). elife (2019) ncbi
mouse monoclonal (FC82291) B0556 immunocytochemistry; human; 1:600; loading ...; fig s7m MilliporeSigma NPM1 antibody (Sigma-Aldrich, B0556) was used in immunocytochemistry on human samples at 1:600 (fig s7m). Nature (2018) ncbi
mouse monoclonal (FC82291) B0556 western blot; mouse; 1:1000; loading ...; fig st3 In order to find the E3 ubiquitin ligase Mule is essential for cardiac homeostasis by regulating mitochondrial function via maintenance of Pgc-1alpha and Pink1 expression and persistent negative regulation of c-Myc, MilliporeSigma NPM1 antibody (Sigma, B0556) was used in western blot on mouse samples at 1:1000 (fig st3). Sci Rep (2017) ncbi
mouse monoclonal (FC82291) B0556 immunocytochemistry; human; 1:1000; loading ...; fig 2hwestern blot; human; 1:500; loading ...; fig 2g MilliporeSigma NPM1 antibody (Sigma-Aldrich, B0556) was used in immunocytochemistry on human samples at 1:1000 (fig 2h) and in western blot on human samples at 1:500 (fig 2g). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (FC82291) B0556 immunocytochemistry; human; 1:200; fig 4 In order to investigate the connection between calorie restriction and magnesium, MilliporeSigma NPM1 antibody (Sigma, B0556) was used in immunocytochemistry on human samples at 1:200 (fig 4). Nucleic Acids Res (2016) ncbi
mouse monoclonal (FC82291) B0556 immunocytochemistry; mouse; loading ...; fig 2ewestern blot; mouse; loading ...; fig 7a In order to elucidate the function of nucleophosmin 1 in the brain, MilliporeSigma NPM1 antibody (Sigma, B0556) was used in immunocytochemistry on mouse samples (fig 2e) and in western blot on mouse samples (fig 7a). J Biol Chem (2016) ncbi
mouse monoclonal (FC82291) B0556 immunocytochemistry; human; 1:100; fig 2 MilliporeSigma NPM1 antibody (Sigma-Aldrich, B0556) was used in immunocytochemistry on human samples at 1:100 (fig 2). Oncol Lett (2016) ncbi
mouse monoclonal (FC82291) B0556 immunocytochemistry; mouse; 1:1000; fig 6 MilliporeSigma NPM1 antibody (Sigma, B0556) was used in immunocytochemistry on mouse samples at 1:1000 (fig 6). BMC Dev Biol (2015) ncbi
mouse monoclonal (FC82291) B0556 immunocytochemistry; mouse; loading ...; fig 2ewestern blot; mouse; loading ...; fig 2dimmunocytochemistry; human; loading ...; fig 3aimmunohistochemistry; human; fig 1awestern blot; human; loading ...; fig 6c MilliporeSigma NPM1 antibody (Sigma, FC82291) was used in immunocytochemistry on mouse samples (fig 2e), in western blot on mouse samples (fig 2d), in immunocytochemistry on human samples (fig 3a), in immunohistochemistry on human samples (fig 1a) and in western blot on human samples (fig 6c). Sci Rep (2015) ncbi
mouse monoclonal (FC82291) B0556 immunocytochemistry; human; fig 7a MilliporeSigma NPM1 antibody (Sigma, B0556) was used in immunocytochemistry on human samples (fig 7a). Mol Cell Biol (2015) ncbi
mouse monoclonal (FC82291) B0556 western blot; mouse; fig s2c MilliporeSigma NPM1 antibody (Sigma, FC82291) was used in western blot on mouse samples (fig s2c). Mol Cell Proteomics (2012) ncbi
  1. Li X, Chen X, Gao J, Xian J, Li Z, Bi L, et al. Loss-of-function Mutations K11E or E271K Lead to Novel Tumor Suppression, Implicate Nucleolar Helicase DDX24 Oncogenicity. Int J Med Sci. 2022;19:596-608 pubmed publisher
  2. Mohan H, Trzeciakiewicz H, Pithadia A, Crowley E, Pacitto R, Safren N, et al. RTL8 promotes nuclear localization of UBQLN2 to subnuclear compartments associated with protein quality control. Cell Mol Life Sci. 2022;79:176 pubmed publisher
  3. Kanellis D, Espinoza J, Zisi A, Sakkas E, Bartkova J, Katsori A, et al. The exon-junction complex helicase eIF4A3 controls cell fate via coordinated regulation of ribosome biogenesis and translational output. Sci Adv. 2021;7: pubmed publisher
  4. Frottin F, Pérez Berlanga M, Hartl F, Hipp M. Multiple pathways of toxicity induced by C9orf72 dipeptide repeat aggregates and G4C2 RNA in a cellular model. elife. 2021;10: pubmed publisher
  5. Höllmüller E, Geigges S, Niedermeier M, Kammer K, Kienle S, Rösner D, et al. Site-specific ubiquitylation acts as a regulator of linker histone H1. Nat Commun. 2021;12:3497 pubmed publisher
  6. Repenning A, Happel D, Bouchard C, Meixner M, Verel Yilmaz Y, Raifer H, et al. PRMT1 promotes the tumor suppressor function of p14ARF and is indicative for pancreatic cancer prognosis. EMBO J. 2021;40:e106777 pubmed publisher
  7. Stadler D, Kächele M, Jones A, Hess J, Urban C, Schneider J, et al. Interferon-induced degradation of the persistent hepatitis B virus cccDNA form depends on ISG20. EMBO Rep. 2021;22:e49568 pubmed publisher
  8. Pham T, Liao R, Labaer J, Guo J. Multiplexed In Situ Protein Profiling with High-Performance Cleavable Fluorescent Tyramide. Molecules. 2021;26: pubmed publisher
  9. Wang X, Zhang H, Sapio R, Yang J, Wong J, Zhang X, et al. SOD1 regulates ribosome biogenesis in KRAS mutant non-small cell lung cancer. Nat Commun. 2021;12:2259 pubmed publisher
  10. Shi L, Magee P, Fassan M, Sahoo S, Leong H, LEE D, et al. A KRAS-responsive long non-coding RNA controls microRNA processing. Nat Commun. 2021;12:2038 pubmed publisher
  11. Liao R, Mondal M, Nazaroff C, Mastroeni D, Coleman P, Labaer J, et al. Highly Sensitive and Multiplexed Protein Imaging With Cleavable Fluorescent Tyramide Reveals Human Neuronal Heterogeneity. Front Cell Dev Biol. 2020;8:614624 pubmed publisher
  12. Freibaum B, Messing J, Yang P, Kim H, Taylor J. High-fidelity reconstitution of stress granules and nucleoli in mammalian cellular lysate. J Cell Biol. 2021;220: pubmed publisher
  13. Ide S, Imai R, Ochi H, Maeshima K. Transcriptional suppression of ribosomal DNA with phase separation. Sci Adv. 2020;6: pubmed publisher
  14. Li Y, Ivica N, Dong T, Papageorgiou D, He Y, Brown D, et al. MFSD7C switches mitochondrial ATP synthesis to thermogenesis in response to heme. Nat Commun. 2020;11:4837 pubmed publisher
  15. Klein I, Boija A, Afeyan L, Hawken S, Fan M, Dall Agnese A, et al. Partitioning of cancer therapeutics in nuclear condensates. Science. 2020;368:1386-1392 pubmed publisher
  16. Kourentzi K, Crum M, Patil U, Prebisch A, Chavan D, Vu B, et al. Recombinant expression, characterization, and quantification in human cancer cell lines of the Anaplastic Large-Cell Lymphoma-characteristic NPM-ALK fusion protein. Sci Rep. 2020;10:5078 pubmed publisher
  17. Gil L, Niño S, Chi Ahumada E, Rodríguez Leyva I, Guerrero C, Rebolledo A, et al. Perinuclear Lamin A and Nucleoplasmic Lamin B2 Characterize Two Types of Hippocampal Neurons through Alzheimer's Disease Progression. Int J Mol Sci. 2020;21: pubmed publisher
  18. Saini N, Sarin A. Nucleolar localization of the Notch4 intracellular domain underpins its regulation of the cellular response to genotoxic stressors. Cell Death Discov. 2020;6:7 pubmed publisher
  19. Frottin F, Schueder F, Tiwary S, Gupta R, Korner R, Schlichthaerle T, et al. The nucleolus functions as a phase-separated protein quality control compartment. Science. 2019;365:342-347 pubmed publisher
  20. Gkatza N, Castro C, Harvey R, Heiß M, Popis M, Blanco S, et al. Cytosine-5 RNA methylation links protein synthesis to cell metabolism. PLoS Biol. 2019;17:e3000297 pubmed publisher
  21. Azkanaz M, Rodríguez López A, de Boer B, Huiting W, Angrand P, Vellenga E, et al. Protein quality control in the nucleolus safeguards recovery of epigenetic regulators after heat shock. elife. 2019;8: pubmed publisher
  22. Singh R, Peng S, Viswanath P, Sambandam V, Shen L, Rao X, et al. Non-canonical cMet regulation by vimentin mediates Plk1 inhibitor-induced apoptosis. EMBO Mol Med. 2019;: pubmed publisher
  23. Brody M, Vanhoutte D, Bakshi C, Liu R, Correll R, Sargent M, et al. Disruption of valosin-containing protein activity causes cardiomyopathy and reveals pleiotropic functions in cardiac homeostasis. J Biol Chem. 2019;294:8918-8929 pubmed publisher
  24. Del Rosario B, Kriz A, Del Rosario A, Anselmo A, Fry C, White F, et al. Exploration of CTCF post-translation modifications uncovers Serine-224 phosphorylation by PLK1 at pericentric regions during the G2/M transition. elife. 2019;8: pubmed publisher
  25. López Erauskin J, Tadokoro T, Baughn M, Myers B, McAlonis Downes M, Chillon Marinas C, et al. ALS/FTD-Linked Mutation in FUS Suppresses Intra-axonal Protein Synthesis and Drives Disease Without Nuclear Loss-of-Function of FUS. Neuron. 2018;100:816-830.e7 pubmed publisher
  26. Zhang J, Zhang Y, Zhao L, Guo J, Yu J, Ji S, et al. Mammalian nucleolar protein DCAF13 is essential for ovarian follicle maintenance and oocyte growth by mediating rRNA processing. Cell Death Differ. 2019;26:1251-1266 pubmed publisher
  27. Rai A, Chen J, Selbach M, Pelkmans L. Kinase-controlled phase transition of membraneless organelles in mitosis. Nature. 2018;559:211-216 pubmed publisher
  28. Marchesini M, Ogoti Y, Fiorini E, Aktaş Samur A, Nezi L, D Anca M, et al. ILF2 Is a Regulator of RNA Splicing and DNA Damage Response in 1q21-Amplified Multiple Myeloma. Cancer Cell. 2017;32:88-100.e6 pubmed publisher
  29. Blank M, Chen S, Poetz F, Schnolzer M, Voit R, Grummt I. SIRT7-dependent deacetylation of CDK9 activates RNA polymerase II transcription. Nucleic Acids Res. 2017;45:2675-2686 pubmed publisher
  30. Douet J, Corujo D, Malinverni R, Renauld J, Sansoni V, Posavec Marjanović M, et al. MacroH2A histone variants maintain nuclear organization and heterochromatin architecture. J Cell Sci. 2017;130:1570-1582 pubmed publisher
  31. Dadson K, Hauck L, Hao Z, Grothe D, Rao V, Mak T, et al. The E3 ligase Mule protects the heart against oxidative stress and mitochondrial dysfunction through Myc-dependent inactivation of Pgc-1α and Pink1. Sci Rep. 2017;7:41490 pubmed publisher
  32. Coccia M, Rossi A, Riccio A, Trotta E, Santoro M. Human NF-κB repressing factor acts as a stress-regulated switch for ribosomal RNA processing and nucleolar homeostasis surveillance. Proc Natl Acad Sci U S A. 2017;114:1045-1050 pubmed publisher
  33. Ren Z, Aerts J, Vandenplas H, Wang J, Gorbenko O, Chen J, et al. Phosphorylated STAT5 regulates p53 expression via BRCA1/BARD1-NPM1 and MDM2. Cell Death Dis. 2016;7:e2560 pubmed publisher
  34. Hoch N, Hanzlikova H, Rulten S, Tetreault M, Komulainen E, Ju L, et al. XRCC1 mutation is associated with PARP1 hyperactivation and cerebellar ataxia. Nature. 2017;541:87-91 pubmed publisher
  35. Lin J, Hisaoka M, Nagata K, Okuwaki M. Functional characterization and efficient detection of Nucleophosmin/NPM1 oligomers. Biochem Biophys Res Commun. 2016;480:702-708 pubmed publisher
  36. Hanzlikova H, Gittens W, Krejcikova K, Zeng Z, Caldecott K. Overlapping roles for PARP1 and PARP2 in the recruitment of endogenous XRCC1 and PNKP into oxidized chromatin. Nucleic Acids Res. 2017;45:2546-2557 pubmed publisher
  37. Huang M, Garcia J, Thomas D, Zhu L, Nguyen L, Chan S, et al. Autophagy mediates proteolysis of NPM1 and HEXIM1 and sensitivity to BET inhibition in AML cells. Oncotarget. 2016;7:74917-74930 pubmed publisher
  38. Kozakai Y, Kamada R, Furuta J, Kiyota Y, Chuman Y, Sakaguchi K. PPM1D controls nucleolar formation by up-regulating phosphorylation of nucleophosmin. Sci Rep. 2016;6:33272 pubmed publisher
  39. Abraham K, Chan J, Salvi J, Ho B, Hall A, Vidya E, et al. Intersection of calorie restriction and magnesium in the suppression of genome-destabilizing RNA-DNA hybrids. Nucleic Acids Res. 2016;44:8870-8884 pubmed
  40. Vickers T, Crooke S. Development of a Quantitative BRET Affinity Assay for Nucleic Acid-Protein Interactions. PLoS ONE. 2016;11:e0161930 pubmed publisher
  41. Okuwaki M, Abe M, Hisaoka M, Nagata K. Regulation of Cellular Dynamics and Chromosomal Binding Site Preference of Linker Histones H1.0 and H1.X. Mol Cell Biol. 2016;36:2681-2696 pubmed publisher
  42. Surtees R, Dowall S, Shaw A, Armstrong S, Hewson R, Carroll M, et al. Heat Shock Protein 70 Family Members Interact with Crimean-Congo Hemorrhagic Fever Virus and Hazara Virus Nucleocapsid Proteins and Perform a Functional Role in the Nairovirus Replication Cycle. J Virol. 2016;90:9305-16 pubmed publisher
  43. Pfister J, D Mello S. Regulation of Neuronal Survival by Nucleophosmin 1 (NPM1) Is Dependent on Its Expression Level, Subcellular Localization, and Oligomerization Status. J Biol Chem. 2016;291:20787-97 pubmed publisher
  44. Li M, Liu D, Wang L, Wang W, Wang A, Yao Y. Expression of placenta-specific 8 in human oocytes, embryos, and models of in vitro implantation. Fertil Steril. 2016;106:781-789.e2 pubmed publisher
  45. Trapé A, Liu S, Cortés A, Ueno N, Gonzalez Angulo A. Effects of CDK4/6 Inhibition in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Cells with Acquired Resistance to Paclitaxel. J Cancer. 2016;7:947-56 pubmed publisher
  46. Li Y, Hu Y, Che L, Jia J, Chen M. Nucleolar localization of Small G protein RhoA is associated with active RNA synthesis in human carcinoma HEp-2 cells. Oncol Lett. 2016;11:3605-3610 pubmed
  47. Mukhopadhyay A, Sehgal L, Bose A, Gulvady A, Senapati P, Thorat R, et al. 14-3-3? Prevents Centrosome Amplification and Neoplastic Progression. Sci Rep. 2016;6:26580 pubmed publisher
  48. Marzahn M, Marada S, Lee J, Nourse A, Kenrick S, Zhao H, et al. Higher-order oligomerization promotes localization of SPOP to liquid nuclear speckles. EMBO J. 2016;35:1254-75 pubmed publisher
  49. Karlsson T, Altankhuyag A, Dobrovolska O, Turcu D, Lewis A. A polybasic motif in ErbB3-binding protein 1 (EBP1) has key functions in nucleolar localization and polyphosphoinositide interaction. Biochem J. 2016;473:2033-47 pubmed publisher
  50. Destouches D, Sader M, Terry S, Marchand C, Maillé P, Soyeux P, et al. Implication of NPM1 phosphorylation and preclinical evaluation of the nucleoprotein antagonist N6L in prostate cancer. Oncotarget. 2016;7:69397-69411 pubmed publisher
  51. Catanzaro G, Besharat Z, Garg N, Ronci M, Pieroni L, Miele E, et al. MicroRNAs-Proteomic Networks Characterizing Human Medulloblastoma-SLCs. Stem Cells Int. 2016;2016:2683042 pubmed publisher
  52. Bober J, Olsnes S, Kostas M, Bogacz M, Zakrzewska M, Otlewski J. Identification of new FGF1 binding partners-Implications for its intracellular function. IUBMB Life. 2016;68:242-51 pubmed publisher
  53. Ceccon M, Merlo M, Mologni L, Poggio T, Varesio L, Menotti M, et al. Excess of NPM-ALK oncogenic signaling promotes cellular apoptosis and drug dependency. Oncogene. 2016;35:3854-3865 pubmed publisher
  54. Popken J, Dahlhoff M, Guengoer T, Wolf E, Zakhartchenko V. 3D structured illumination microscopy of mammalian embryos and spermatozoa. BMC Dev Biol. 2015;15:46 pubmed publisher
  55. Ponti D, Bastianelli D, Rosa P, Pacini L, Ibrahim M, Rendina E, et al. The expression of B23 and EGR1 proteins is functionally linked in tumor cells under stress conditions. BMC Cell Biol. 2015;16:27 pubmed publisher
  56. Holmberg Olausson K, Elsir T, Moazemi Goudarzi K, Nistér M, Lindström M. NPM1 histone chaperone is upregulated in glioblastoma to promote cell survival and maintain nucleolar shape. Sci Rep. 2015;5:16495 pubmed publisher
  57. Wandrey F, Montellese C, Koos K, Badertscher L, Bammert L, Cook A, et al. The NF45/NF90 Heterodimer Contributes to the Biogenesis of 60S Ribosomal Subunits and Influences Nucleolar Morphology. Mol Cell Biol. 2015;35:3491-503 pubmed publisher
  58. Neo S, Itahana Y, Alagu J, Kitagawa M, Guo A, Lee S, et al. TRIM28 Is an E3 Ligase for ARF-Mediated NPM1/B23 SUMOylation That Represses Centrosome Amplification. Mol Cell Biol. 2015;35:2851-63 pubmed publisher
  59. Sokka M, Rilla K, Miinalainen I, Pospiech H, Syväoja J. High levels of TopBP1 induce ATR-dependent shut-down of rRNA transcription and nucleolar segregation. Nucleic Acids Res. 2015;43:4975-89 pubmed publisher
  60. Vishwamitra D, Curry C, Alkan S, Song Y, Gallick G, Kaseb A, et al. The transcription factors Ik-1 and MZF1 downregulate IGF-IR expression in NPM-ALK⁺ T-cell lymphoma. Mol Cancer. 2015;14:53 pubmed publisher
  61. Tancioni I, Miller N, Uryu S, Lawson C, Jean C, Chen X, et al. FAK activity protects nucleostemin in facilitating breast cancer spheroid and tumor growth. Breast Cancer Res. 2015;17:47 pubmed publisher
  62. Jørgensen M, Bæk R, Varming K. Potentials and capabilities of the Extracellular Vesicle (EV) Array. J Extracell Vesicles. 2015;4:26048 pubmed publisher
  63. Perera Y, Pedroso S, Borras Hidalgo O, Vázquez D, Miranda J, Villareal A, et al. Pharmacologic inhibition of the CK2-mediated phosphorylation of B23/NPM in cancer cells selectively modulates genes related to protein synthesis, energetic metabolism, and ribosomal biogenesis. Mol Cell Biochem. 2015;404:103-12 pubmed publisher
  64. Martelli M, Gionfriddo I, Mezzasoma F, Milano F, Pierangeli S, Mulas F, et al. Arsenic trioxide and all-trans retinoic acid target NPM1 mutant oncoprotein levels and induce apoptosis in NPM1-mutated AML cells. Blood. 2015;125:3455-65 pubmed publisher
  65. Holley C, Li M, Scruggs B, Matkovich S, Ory D, Schaffer J. Cytosolic accumulation of small nucleolar RNAs (snoRNAs) is dynamically regulated by NADPH oxidase. J Biol Chem. 2015;290:11741-8 pubmed publisher
  66. Fujiwara Y, Hase K, Wada K, Kabuta T. An RNautophagy/DNautophagy receptor, LAMP2C, possesses an arginine-rich motif that mediates RNA/DNA-binding. Biochem Biophys Res Commun. 2015;460:281-6 pubmed publisher
  67. Katagiri N, Kuroda T, Kishimoto H, Hayashi Y, Kumazawa T, Kimura K. The nucleolar protein nucleophosmin is essential for autophagy induced by inhibiting Pol I transcription. Sci Rep. 2015;5:8903 pubmed publisher
  68. Arnoldo L, Sgarra R, Chiefari E, Iiritano S, Arcidiacono B, Pegoraro S, et al. A novel mechanism of post-translational modulation of HMGA functions by the histone chaperone nucleophosmin. Sci Rep. 2015;5:8552 pubmed publisher
  69. Wang L, Liu R, Ye P, Wong C, Chen G, Zhou P, et al. Intracellular CD24 disrupts the ARF-NPM interaction and enables mutational and viral oncogene-mediated p53 inactivation. Nat Commun. 2015;6:5909 pubmed publisher
  70. Pekkonen P, Järviluoma A, Zinovkina N, Cvrljevic A, Prakash S, Westermarck J, et al. KSHV viral cyclin interferes with T-cell development and induces lymphoma through Cdk6 and Notch activation in vivo. Cell Cycle. 2014;13:3670-84 pubmed publisher
  71. Lindenboim L, Sasson T, Worman H, Borner C, Stein R. Cellular stress induces Bax-regulated nuclear bubble budding and rupture followed by nuclear protein release. Nucleus. 2014;5:527-41 pubmed publisher
  72. Khalouei S, Chow A, Brown I. Localization of heat shock protein HSPA6 (HSP70B') to sites of transcription in cultured differentiated human neuronal cells following thermal stress. J Neurochem. 2014;131:743-54 pubmed publisher
  73. Raman N, Nayak A, Muller S. mTOR signaling regulates nucleolar targeting of the SUMO-specific isopeptidase SENP3. Mol Cell Biol. 2014;34:4474-84 pubmed publisher
  74. Peltonen K, Colis L, Liu H, Jäämaa S, Zhang Z, Af Hällström T, et al. Small molecule BMH-compounds that inhibit RNA polymerase I and cause nucleolar stress. Mol Cancer Ther. 2014;13:2537-46 pubmed publisher
  75. Flach J, Bakker S, Mohrin M, Conroy P, Pietras E, Reynaud D, et al. Replication stress is a potent driver of functional decline in ageing haematopoietic stem cells. Nature. 2014;512:198-202 pubmed publisher
  76. Hamilton G, Abraham A, Morton J, Sampson O, Pefani D, Khoronenkova S, et al. AKT regulates NPM dependent ARF localization and p53mut stability in tumors. Oncotarget. 2014;5:6142-67 pubmed
  77. Smith C, Matheson T, Trombly D, Sun X, Campeau E, Han X, et al. A separable domain of the p150 subunit of human chromatin assembly factor-1 promotes protein and chromosome associations with nucleoli. Mol Biol Cell. 2014;25:2866-81 pubmed publisher
  78. Lührig S, Siamishi I, Tesmer Wolf M, Zechner U, Engel W, Nolte J. Lrrc34, a novel nucleolar protein, interacts with npm1 and ncl and has an impact on pluripotent stem cells. Stem Cells Dev. 2014;23:2862-74 pubmed publisher
  79. Shaiken T, Opekun A. Dissecting the cell to nucleus, perinucleus and cytosol. Sci Rep. 2014;4:4923 pubmed publisher
  80. Munne P, Gu Y, Tumiati M, Gao P, Koopal S, Uusivirta S, et al. TP53 supports basal-like differentiation of mammary epithelial cells by preventing translocation of deltaNp63 into nucleoli. Sci Rep. 2014;4:4663 pubmed publisher
  81. Leal M, Mazzotti T, Calcagno D, Cirilo P, Martinez M, Demachki S, et al. Deregulated expression of Nucleophosmin 1 in gastric cancer and its clinicopathological implications. BMC Gastroenterol. 2014;14:9 pubmed publisher
  82. Du G, Stinski M. Interaction network of proteins associated with human cytomegalovirus IE2-p86 protein during infection: a proteomic analysis. PLoS ONE. 2013;8:e81583 pubmed publisher
  83. Malik Soni N, Frappier L. Nucleophosmin contributes to the transcriptional activation function of the Epstein-Barr virus EBNA1 protein. J Virol. 2014;88:2323-6 pubmed publisher
  84. Lin Y, Chen Y, Cohen S, Cheng T. Identification of TSG101 functional domains and p21 loci required for TSG101-mediated p21 gene regulation. PLoS ONE. 2013;8:e79674 pubmed publisher
  85. de Poot S, Lai K, van der Wal L, Plasman K, Van Damme P, Porter A, et al. Granzyme M targets topoisomerase II alpha to trigger cell cycle arrest and caspase-dependent apoptosis. Cell Death Differ. 2014;21:416-26 pubmed publisher
  86. Bai B, Moore H, Laiho M. CRM1 and its ribosome export adaptor NMD3 localize to the nucleolus and affect rRNA synthesis. Nucleus. 2013;4:315-25 pubmed publisher
  87. Harrison Pitner M, Saavedra H. Cdk4 and nek2 signal binucleation and centrosome amplification in a her2+ breast cancer model. PLoS ONE. 2013;8:e65971 pubmed publisher
  88. Foroni L, Vasuri F, Valente S, Gualandi C, Focarete M, Caprara G, et al. The role of 3D microenvironmental organization in MCF-7 epithelial-mesenchymal transition after 7 culture days. Exp Cell Res. 2013;319:1515-22 pubmed publisher
  89. Noguera N, Song M, Divona M, Catalano G, Calvo K, Garcia F, et al. Nucleophosmin/B26 regulates PTEN through interaction with HAUSP in acute myeloid leukemia. Leukemia. 2013;27:1037-43 pubmed publisher
  90. Fukawa T, Ono M, Matsuo T, Uehara H, Miki T, Nakamura Y, et al. DDX31 regulates the p53-HDM2 pathway and rRNA gene transcription through its interaction with NPM1 in renal cell carcinomas. Cancer Res. 2012;72:5867-77 pubmed publisher
  91. Lin H, Lin Y, Hsu F. Preparation and characterization of mesoporous bioactive glass/polycaprolactone nanofibrous matrix for bone tissues engineering. J Mater Sci Mater Med. 2012;23:2619-30 pubmed publisher
  92. Mercier I, Camacho J, Titchen K, Gonzales D, Quann K, Bryant K, et al. Caveolin-1 and accelerated host aging in the breast tumor microenvironment: chemoprevention with rapamycin, an mTOR inhibitor and anti-aging drug. Am J Pathol. 2012;181:278-93 pubmed publisher
  93. Li Z, Hann S. Nucleophosmin is essential for c-Myc nucleolar localization and c-Myc-mediated rDNA transcription. Oncogene. 2013;32:1988-94 pubmed publisher
  94. Weston D, Adams N, Russell R, Stephens D, Freemont P. Analysis of spatial point patterns in nuclear biology. PLoS ONE. 2012;7:e36841 pubmed publisher
  95. Tondeleir D, Lambrechts A, Muller M, Jonckheere V, Doll T, Vandamme D, et al. Cells lacking ?-actin are genetically reprogrammed and maintain conditional migratory capacity. Mol Cell Proteomics. 2012;11:255-71 pubmed publisher
  96. Perera Y, Costales H, Diaz Y, Reyes O, Farina H, Mendez L, et al. Sensitivity of tumor cells towards CIGB-300 anticancer peptide relies on its nucleolar localization. J Pept Sci. 2012;18:215-23 pubmed publisher
  97. Sari A, Calli A, Altinboga A, Pehlivan F, Görgel S, Balci U, et al. Nucleophosmin expression in renal cell carcinoma and oncocytoma. APMIS. 2012;120:187-94 pubmed publisher
  98. Tsai S, Liou H, Lin C, Kuo K, Hung Y, Weng R, et al. MG63 osteoblast-like cells exhibit different behavior when grown on electrospun collagen matrix versus electrospun gelatin matrix. PLoS ONE. 2012;7:e31200 pubmed publisher
  99. Saporita A, Chang H, Winkeler C, Apicelli A, Kladney R, Wang J, et al. RNA helicase DDX5 is a p53-independent target of ARF that participates in ribosome biogenesis. Cancer Res. 2011;71:6708-17 pubmed publisher
  100. Calli A, Sari A, Evcim G, Altinboga A, Sadullahoglu C, Ermete M. The enigmatic role of nucleophosmin in malignant melanoma: does it have an effect?. Indian J Pathol Microbiol. 2011;54:482-6 pubmed publisher
  101. de Koning P, Kummer J, de Poot S, Quadir R, Broekhuizen R, McGettrick A, et al. Intracellular serine protease inhibitor SERPINB4 inhibits granzyme M-induced cell death. PLoS ONE. 2011;6:e22645 pubmed publisher
  102. Østrup O, Hyttel P, Klærke D, Collas P. Remodeling of ribosomal genes in somatic cells by Xenopus egg extract. Biochem Biophys Res Commun. 2011;412:487-93 pubmed publisher
  103. Teittinen K, Kärkkäinen P, Salonen J, Rönnholm G, Korkeamäki H, Vihinen M, et al. Nucleolar proteins with altered expression in leukemic cell lines. Leuk Res. 2012;36:232-6 pubmed publisher
  104. Donati G, Bertoni S, Brighenti E, Vici M, Trere D, Volarevic S, et al. The balance between rRNA and ribosomal protein synthesis up- and downregulates the tumour suppressor p53 in mammalian cells. Oncogene. 2011;30:3274-88 pubmed publisher
  105. Finkbeiner E, Haindl M, Muller S. The SUMO system controls nucleolar partitioning of a novel mammalian ribosome biogenesis complex. EMBO J. 2011;30:1067-78 pubmed publisher
  106. Welcker M, Larimore E, Frappier L, Clurman B. Nucleolar targeting of the fbw7 ubiquitin ligase by a pseudosubstrate and glycogen synthase kinase 3. Mol Cell Biol. 2011;31:1214-24 pubmed publisher
  107. Dutt S, Narla A, Lin K, Mullally A, Abayasekara N, Megerdichian C, et al. Haploinsufficiency for ribosomal protein genes causes selective activation of p53 in human erythroid progenitor cells. Blood. 2011;117:2567-76 pubmed publisher
  108. Lewis A, Sommer L, Arntzen M, Strahm Y, Morrice N, Divecha N, et al. Identification of nuclear phosphatidylinositol 4,5-bisphosphate-interacting proteins by neomycin extraction. Mol Cell Proteomics. 2011;10:M110.003376 pubmed publisher
  109. Fantini D, Vascotto C, Marasco D, D Ambrosio C, Romanello M, Vitagliano L, et al. Critical lysine residues within the overlooked N-terminal domain of human APE1 regulate its biological functions. Nucleic Acids Res. 2010;38:8239-56 pubmed publisher
  110. Zhu Z, Wang Y, Li X, Wang Y, Xu L, Wang X, et al. PHF8 is a histone H3K9me2 demethylase regulating rRNA synthesis. Cell Res. 2010;20:794-801 pubmed publisher
  111. Kawagishi H, Nakamura H, Maruyama M, Mizutani S, Sugimoto K, Takagi M, et al. ARF suppresses tumor angiogenesis through translational control of VEGFA mRNA. Cancer Res. 2010;70:4749-58 pubmed publisher
  112. Rees Unwin K, Faragher R, Unwin R, Adams J, Brown P, Buckle A, et al. Ribosome-associated nucleophosmin 1: increased expression and shuttling activity distinguishes prognostic subtypes in chronic lymphocytic leukaemia. Br J Haematol. 2010;148:534-43 pubmed publisher
  113. Pitulescu M, Teichmann M, Luo L, Kessel M. TIPT2 and geminin interact with basal transcription factors to synergize in transcriptional regulation. BMC Biochem. 2009;10:16 pubmed publisher
  114. Duxin J, Dao B, Martinsson P, Rajala N, Guittat L, Campbell J, et al. Human Dna2 is a nuclear and mitochondrial DNA maintenance protein. Mol Cell Biol. 2009;29:4274-82 pubmed publisher
  115. Di Tommaso A, Hagen J, Tompkins V, Muniz V, Dudakovic A, Kitzis A, et al. Residues in the alternative reading frame tumor suppressor that influence its stability and p53-independent activities. Exp Cell Res. 2009;315:1326-35 pubmed publisher
  116. Vascotto C, Fantini D, Romanello M, Cesaratto L, Deganuto M, Leonardi A, et al. APE1/Ref-1 interacts with NPM1 within nucleoli and plays a role in the rRNA quality control process. Mol Cell Biol. 2009;29:1834-54 pubmed publisher
  117. Zhang J, Tomasini A, Mayer A. RBM19 is essential for preimplantation development in the mouse. BMC Dev Biol. 2008;8:115 pubmed publisher
  118. Itahana K, Zhang Y. Mitochondrial p32 is a critical mediator of ARF-induced apoptosis. Cancer Cell. 2008;13:542-53 pubmed publisher
  119. Yogev O, Saadon K, Anzi S, Inoue K, Shaulian E. DNA damage-dependent translocation of B23 and p19 ARF is regulated by the Jun N-terminal kinase pathway. Cancer Res. 2008;68:1398-406 pubmed publisher
  120. Apicelli A, Maggi L, Hirbe A, Miceli A, Olanich M, Schulte Winkeler C, et al. A non-tumor suppressor role for basal p19ARF in maintaining nucleolar structure and function. Mol Cell Biol. 2008;28:1068-80 pubmed
  121. Korkeamäki H, Viiri K, Kukkonen M, Maki M, Lohi O. Alternative mRNA splicing of SAP30L regulates its transcriptional repression activity. FEBS Lett. 2008;582:379-84 pubmed
  122. Frescas D, Guardavaccaro D, Bassermann F, Koyama Nasu R, Pagano M. JHDM1B/FBXL10 is a nucleolar protein that represses transcription of ribosomal RNA genes. Nature. 2007;450:309-13 pubmed
  123. Moulin S, Llanos S, Kim S, Peters G. Binding to nucleophosmin determines the localization of human and chicken ARF but not its impact on p53. Oncogene. 2008;27:2382-9 pubmed
  124. Gerashchenko B, Yamagata A, Oofusa K, Yoshizato K, De Toledo S, Howell R. Proteome analysis of proliferative response of bystander cells adjacent to cells exposed to ionizing radiation. Proteomics. 2007;7:2000-8 pubmed
  125. Bergstralh D, Conti B, Moore C, Brickey W, Taxman D, Ting J. Global functional analysis of nucleophosmin in Taxol response, cancer, chromatin regulation, and ribosomal DNA transcription. Exp Cell Res. 2007;313:65-76 pubmed
  126. Viiri K, Korkeamäki H, Kukkonen M, Nieminen L, Lindfors K, Peterson P, et al. SAP30L interacts with members of the Sin3A corepressor complex and targets Sin3A to the nucleolus. Nucleic Acids Res. 2006;34:3288-98 pubmed
  127. Falini B, Martelli M, Bolli N, Bonasso R, Ghia E, Pallotta M, et al. Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia. Blood. 2006;108:1999-2005 pubmed
  128. Kinumi T, Ogawa Y, Kimata J, Saito Y, Yoshida Y, Niki E. Proteomic characterization of oxidative dysfunction in human umbilical vein endothelial cells (HUVEC) induced by exposure to oxidized LDL. Free Radic Res. 2005;39:1335-44 pubmed
  129. Wang W, Budhu A, Forgues M, Wang X. Temporal and spatial control of nucleophosmin by the Ran-Crm1 complex in centrosome duplication. Nat Cell Biol. 2005;7:823-30 pubmed